Amgen Inc. (AMGN) FY2024 Q3 Balance Sheet

Amgen Inc. (AMGN) FY2024 Q3 Balance Sheet

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

Assets

90,883,000,000 US dollars

Current assets

26,766,000,000 US dollars

Non-current assets

64,117,000,000 US dollars

Liabilities (calculated)

83,356,000,000 US dollars

Current liabilities

20,312,000,000 US dollars

Non-current liabilities

63,044,000,000 US dollars

Equity

7,527,000,000 US dollars

Cash and cash equivalents

9,011,000,000 US dollars

Inventories

7,362,000,000 US dollars

Trade receivables, net

7,317,000,000 US dollars

Other current assets

3,076,000,000 US dollars

Intangible assets, net

28,920,000,000 US dollars

Goodwill

18,658,000,000 US dollars

Other noncurrent assets

10,383,000,000 US dollars

Property, plant and equipment, net

6,156,000,000 US dollars

Accrued liabilities

14,621,000,000 US dollars

Current portion of long-term debt

3,544,000,000 US dollars

Accounts payable

2,147,000,000 US dollars

Long-term debt

56,854,000,000 US dollars

Long-term tax liabilities

2,280,000,000 US dollars

Other noncurrent liabilities

2,199,000,000 US dollars

Long-term deferred tax liabilities

1,711,000,000 US dollars

Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding—537.5 shares in 2024 and 535.4 shares in 2023

33,393,000,000 US dollars

Accumulated deficit

negative 25,530,000,000 US dollars

Accumulated other comprehensive loss

negative 336,000,000 US dollars

Gross equity (calculated)

33,393,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.